D.E. Shaw & Co
KNTE

D.E. Shaw & Co’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

D.E. Shaw & Co’s Portfolio KNTE Stock Details KNTE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$357K Buy
2023
Q3 		$78.1K Sell
2023
Q2 		$182K Buy
2022
Q1 		– Sell
2021
Q4 		$248K Sell
2021
Q3 		$655K Buy
2021
Q2 		$483K Sell
2021
Q1 		$712K Buy